Alanna Strong Selected Research

Kidney Diseases (Kidney Disease)

1/2021

A new syndrome of moyamoya disease, kidney dysplasia, aminotransferase elevation, and skin disease associated with de novo variants in RNF213.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alanna Strong Research Topics

Disease

6	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 10/2010
4	Myocardial Infarction 01/2018 - 08/2010
2	Congenital Heart Defects (Congenital Heart Defect) 12/2023 - 01/2023
2	Moyamoya Disease (Moya-Moya Disease) 10/2023 - 01/2021
2	Wolman Disease (Wolman's Disease) 01/2022 - 01/2020
2	Tetralogy of Fallot (Fallot Tetralogy) 10/2021 - 10/2021
2	Coronary Artery Disease (Coronary Atherosclerosis) 02/2015 - 05/2012
1	Aortic Coarctation 12/2023
1	Patent Ductus Arteriosus 12/2023
1	Fructose Intolerance (Intolerance, Fructose) 11/2023
1	Stroke (Strokes) 10/2023
1	Leigh Disease (Leigh's Disease) 10/2023
1	Orofaciodigital Syndromes (Orofaciodigital Syndrome) 01/2023
1	Ciliopathies 01/2023
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 01/2023
1	Craniosynostoses (Craniosynostosis) 08/2022
1	And Kidney Dysplasia-Hypoplasia Cleft Palate-Cryptorchidism Ear-Eye Anomalies Hirschsprung Disease Skeletal Malformations Ectodermal Dysplasia Retardation Brain Anomalies 01/2022
1	Ichthyosis follicularis atrichia photophobia syndrome 01/2022
1	Skin Diseases (Skin Disease) 01/2021
1	Kidney Diseases (Kidney Disease) 01/2021
1	Dyslipidemias (Dyslipidemia) 01/2020
1	Hypertension (High Blood Pressure) 01/2018
1	Disease Progression 01/2018
1	Cardiomyopathies (Cardiomyopathy) 01/2017
1	Atherosclerosis 02/2015
1	Seizures (Absence Seizure) 09/2014
1	Obesity 05/2012

Drug/Important Bio-Agent (IBA)

9	LDL CholesterolIBA 01/2018 - 08/2010
6	oxidized low density lipoproteinIBA 01/2018 - 08/2010
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 10/2021 - 10/2021
2	Triglycerides (Triacylglycerol)IBA 01/2020 - 05/2012
2	sortilinIBA 02/2015 - 10/2014
1	Coenzyme A (CoA)IBA 12/2023
1	Congenital disorder of glycosylation type 1AIBA 11/2023
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 10/2023
1	ZincIBA 10/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	Amino Acids FDA Link 01/2023
1	Serine (L-Serine)FDA Link 01/2023
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2023
1	Arginine (L-Arginine)FDA Link 01/2023
1	ChromatinIBA 08/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	Peptide Hydrolases (Proteases)FDA Link 01/2022
1	SterolsIBA 01/2022
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 10/2021
1	Transaminases (Aminotransferases)IBA 01/2021
1	Sebelipase alfaIBA 01/2020
1	Cholesterol Esters (Cholesteryl Esters)IBA 01/2020
1	EnzymesIBA 01/2020
1	Arginine Vasopressin (Argipressin)IBA 01/2018
1	Isosorbide Dinitrate (Isordil)FDA LinkGeneric 01/2018
1	Tolvaptan FDA Link 01/2018
1	CytokinesIBA 02/2015
1	LipopolysaccharidesIBA 02/2015
1	Lipoproteins (Lipoprotein)IBA 10/2014
1	Quinidine (Chinidin)FDA LinkGeneric 09/2014
1	Proprotein Convertase 9IBA 08/2014
1	Apolipoproteins B (ApoB)IBA 05/2012
1	Mechanistic Target of Rapamycin Complex 1IBA 05/2012
1	TOR Serine-Threonine KinasesIBA 05/2012
1	Sirolimus (Rapamycin)FDA Link 05/2012
1	HDL CholesterolIBA 10/2010
1	LipidsIBA 10/2010

Therapy/Procedure

3	Therapeutics 01/2023 - 01/2017
2	Enzyme Replacement Therapy 01/2022 - 01/2020
1	Sutures (Suture) 08/2022